Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2025 11:08 ET | Source: Transparency Market Research

Live Biotherapeutics Market Outlook 2034: Accelerating at 14% CAGR, Projected to Reach US$ 422.9 Million, Latest Report by TMR

Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The Global Live Biotherapeutics Market (라이브 바이오테라퓨틱스 시장), valued at US$ 105.5 Mn in 2023, is set for...
May 10, 2023 09:00 ET | Source: G-Tech Medical

Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023

MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System...
May 09, 2023 09:00 ET | Source: G-Tech Medical

Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission

MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of...
March 29, 2023 15:30 ET | Source: Transparency Market Research

USD 44 Bn Medical Foods Market to Grow at a CAGR of 7.5% During 2023 to 2031 | Transparency Market Research

Wilmington, Delaware, United States, March 30, 2023 (GLOBE NEWSWIRE) -- According to market research conducted by TMR, the global medical foods industry was valued at USD 23.0 Bn in 2022 and is...
January 13, 2022 09:00 ET | Source: G-Tech Medical

G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System

MOUNTAIN VIEW, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and...
October 29, 2020 12:05 ET | Source: AzurRx BioPharma, Inc.

AzurRx BioPharma Provides Insight into Drawbacks of Using Porcine Products in Production of Pharmaceuticals and Medicinals, Offers Update on Efforts to Produce Synthetic Alternatives

NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“AzurRx” or the “Company”), a New York-based biopharmaceutical company specializing in the...
April 17, 2018 04:00 ET | Source: Global Market Insights, Inc

PEGylated Drugs Market in Europe and North America worth over $10.5 billion by 2024: Global Market Insights, Inc.

Sellbyville, Delaware, April 17, 2018 (GLOBE NEWSWIRE) -- North America and Europe PEGylated Drugs Market is expected to surpass USD 10.5 billion by 2024; according to a new research report by...